C&R Research Balance Sheet Health

Financial Health criteria checks 5/6

C&R Research has a total shareholder equity of ₩45.0B and total debt of ₩5.0B, which brings its debt-to-equity ratio to 11.1%. Its total assets and total liabilities are ₩79.5B and ₩34.5B respectively. C&R Research's EBIT is ₩5.7B making its interest coverage ratio -594.6. It has cash and short-term investments of ₩13.0B.

Key information

11.1%

Debt to equity ratio

₩5.00b

Debt

Interest coverage ratio-594.6x
Cash₩13.01b
Equity₩44.97b
Total liabilities₩34.50b
Total assets₩79.46b

Recent financial health updates

No updates

Recent updates

Here's Why We Think C&R Research (KOSDAQ:359090) Is Well Worth Watching

Sep 20
Here's Why We Think C&R Research (KOSDAQ:359090) Is Well Worth Watching

Financial Position Analysis

Short Term Liabilities: A359090's short term assets (₩38.9B) exceed its short term liabilities (₩31.7B).

Long Term Liabilities: A359090's short term assets (₩38.9B) exceed its long term liabilities (₩2.8B).


Debt to Equity History and Analysis

Debt Level: A359090 has more cash than its total debt.

Reducing Debt: Insufficient data to determine if A359090's debt to equity ratio has reduced over the past 5 years.

Debt Coverage: A359090's debt is well covered by operating cash flow (147.4%).

Interest Coverage: A359090 earns more interest than it pays, so coverage of interest payments is not a concern.


Balance Sheet


Discover healthy companies